| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/15/2010 | US20100092471 Porphyromonas Gingivalis Polypeptides Useful in the Prevention of Periodontal Disease |
| 04/15/2010 | US20100092470 Antibodies, analogs and uses thereof |
| 04/15/2010 | US20100092467 Prevention of tissue ischemia, related methods and compositions |
| 04/15/2010 | US20100092460 Amino acid sequences directed against chemokines and polypeptides comprising the same for the treatment of chemokine-related diseases and disorders |
| 04/15/2010 | US20100092459 Protein Complex and Uses |
| 04/15/2010 | US20100092458 Regulation of apg8 phosphorylation and uses thereof |
| 04/15/2010 | US20100092457 Diagnosis and Treatment of Cancer Using Anti-Desmoglein-3 Antibodies |
| 04/15/2010 | US20100092455 Novel anti-proliferation antibodies |
| 04/15/2010 | US20100092436 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 04/15/2010 | CA2743361A1 Methods and systems for predicting misfolded protein epitopes |
| 04/15/2010 | CA2740098A1 Tcr complex immunotherapeutics |
| 04/15/2010 | CA2740079A1 Methods of making concentrated fibrinogen- and platelet-containing compositions |
| 04/15/2010 | CA2739122A1 Bispecific anti-vegf/anti-ang-2 antibodies |
| 04/15/2010 | CA2737259A1 Epitopes derived from satb2 and uses thereof |
| 04/14/2010 | EP2175271A1 Test method on feline vaccinated with feline immunodeficiency virus vaccine, and antigen for use in the test |
| 04/14/2010 | EP2175017A1 Pseudomonas aeruginosa outer membrane protein pa4710 |
| 04/14/2010 | EP2175016A1 Anti-prominin-1 antibody having adcc activity or cdc activity |
| 04/14/2010 | EP2174958A1 Antibodies derived from anti ed-b l19 and targeting tumor vasculature |
| 04/14/2010 | EP2174957A1 Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof |
| 04/14/2010 | EP2174956A1 Compositions for anti-fibrinolitic treatment |
| 04/14/2010 | EP2174954A1 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 04/14/2010 | EP2174953A1 Compositions and methods for the diagnosis and treatment of tumor |
| 04/14/2010 | EP2174946A1 Methods for chemically synthesizing immunoglobulin chimeric proteins |
| 04/14/2010 | EP2174667A1 Agent for treatment of ophthalmia containing interleukin-6 receptor inhibitor as active ingredient |
| 04/14/2010 | EP2174664A1 New virulence factors of Streptococcus pneumoniae |
| 04/14/2010 | EP2174142A2 Use of a camelid single-domain antibody for detecting an oligomeric form of an amyloid beta peptide and its applications |
| 04/14/2010 | EP2173866A2 Vaccine production for pathogenic bird viral diseases |
| 04/14/2010 | EP2173772A2 Providing improved immunoglobulin sequences by mutating cdr and/or fr positions |
| 04/14/2010 | EP2173771A1 Antibodies against human cytomegalovirus (hcmv) |
| 04/14/2010 | EP2173759A1 Oligosialic acid derivatives, methods of manufacture, and immunological uses |
| 04/14/2010 | EP2173378A2 Complexes of il-15 and il-15ralpha and uses thereof |
| 04/14/2010 | EP2173377A1 Antibody-endostatin fusion protein and its variants |
| 04/14/2010 | EP1786838B1 Compositions and methods for the diagnosis and treatment of tumor |
| 04/14/2010 | EP1440085B1 Transient immortalization of cells by oncogenic proteins or telomerase |
| 04/14/2010 | EP1423704B1 Diagnostic and therapeutic use of f-box proteins for alzheimer's disease and related neurodegenerative disorders |
| 04/14/2010 | EP1409016B1 Antibodies to opgl |
| 04/14/2010 | EP1406928B1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 04/14/2010 | EP1399483B1 Antibodies to insulin-like growth factor i receptor |
| 04/14/2010 | EP1322749B1 Assay for rapid detection of human activated protein c and highly specific monoclonal antibody therefor |
| 04/14/2010 | EP1305418B1 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 04/14/2010 | EP0964693B1 Novel bacteriocins, transport and vector system and method of use thereof |
| 04/14/2010 | EP0961833B1 Human plasma hyaluronidase |
| 04/14/2010 | EP0831903B1 Connective tissue growth factor |
| 04/14/2010 | CN1767852B Antibody vaccine conjugates and uses therefor |
| 04/14/2010 | CN101693742A anti-igf-i receptor antibody |
| 04/14/2010 | CN101693736A Novel peptides |
| 04/13/2010 | US7696339 Nucleic acid encoding monkey QRFP |
| 04/13/2010 | US7696338 Immunotoxin fusion proteins and means for expression thereof |
| 04/13/2010 | US7696330 detecting a Severe Acute Respiratory Syndrome Coronavirus (SARS-Co-V); |
| 04/13/2010 | US7696329 Immunoglobulin peptides against heated bovine blood |
| 04/13/2010 | US7696328 N-carbobenzyloxy (N-CBZ)-deprotecting enzyme and uses therefor |
| 04/13/2010 | US7696327 for treating septic shock by administering to a patient an effective amount of an antagonist of a PRO285, PRO286 or PRO358 polypeptide |
| 04/13/2010 | US7696325 Polypeptide inducing apoptosis |
| 04/13/2010 | US7696324 Humanized antibodies |
| 04/13/2010 | US7696323 chimeric constructs consisting of constant domains of the IgY heavy chain and mammalian immunoglobulin domains that were found to be responsible for the higher molecular stability of mammalian immunoglobulins under acidic conditions; for peroral therapeutic applications |
| 04/13/2010 | US7696322 Heavy and light chain peptides; generating antibody genes; binding to antigens |
| 04/13/2010 | US7696321 Molecules and methods for inhibiting shedding of KIM-1 |
| 04/13/2010 | US7696320 treatment and prevention of cell proliferative and inflammatory disorders; drug delivery device is for simultaneously administering to a subject anti-VEGF treatment and anti-EGFR treatment |
| 04/13/2010 | US7696319 PRO1772 antibodies |
| 04/13/2010 | US7696316 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor |
| 04/13/2010 | US7696308 Fabricated in baculovirus; for penetration into human erythrocytes in event of infection; vaccines against malaria |
| 04/13/2010 | US7696307 inhibiting cell growth and metastasis and treat cancer ; A Disintegrin And Metalloproteinase with ThromboSpondin motifs (ADAMTS) |
| 04/13/2010 | US7696172 culture product produced by culturing a recombinant host cell under suitable conditions to express the polypeptide; has an oncogenic activity; treating liver disorder cirrhosis, or pancreas disorder |
| 04/13/2010 | US7696154 Administering formulation comprising polypeptide and muteins, fused proteins, muteins, functional derivatives and active fragments for treating autoimmune diseases, Type I diabetes, rheumatoid arthritis, graft rejections, inflammatory bowel disease, sepsis, multiple sclerosis, ischemic heart disease etc. |
| 04/13/2010 | US7696151 Providing a screening assay having stearoyl-CoA desaturase biological activity, contacting sceening assay with a test compound and measuring the biological activity |
| 04/13/2010 | US7695962 Polypeptides and nucleic acids encoding same |
| 04/13/2010 | US7695948 Metalloprotease specific immunoglobulin for use in treatment of cell proliferative, nervous system inflammatory, reperfusion and cardiovascular disorders; directed protein evolution |
| 04/13/2010 | US7695940 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 04/13/2010 | US7695936 Knobs and holes heteromeric polypeptides |
| 04/13/2010 | US7695929 Derivatives containing oxazole, pyrazole, thiazole, nitroaryl compound, benzofurazan, triterpene, urea, thiourea, rotenoid, coumarin or cyclolignan such as 4-(2-hydroxyphenyl)-1H-benzo[b][1,4]diazepine-2(3H)-one; multiplexed diagnostic assay for multiple targets in sample; antibodies; kits |
| 04/13/2010 | US7695927 Detection of hypertension using glucuronidated metabolic products |
| 04/13/2010 | US7695715 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 04/13/2010 | CA2418848C Cng2b: a novel human cyclic nucleotide-gated ion channel |
| 04/13/2010 | CA2350080C Novel serine protease bssp2 |
| 04/13/2010 | CA2330206C Poly(adp-ribose) polymerase gene |
| 04/13/2010 | CA2265500C Novel semaphorin gene: semaphorin y |
| 04/13/2010 | CA2257357C Humanized antibodies with modified glycosylation |
| 04/13/2010 | CA2224003C Fluorescence resonance energy transfer screening assay for the identification of hiv-1 envelope glycoprotein-medicated cell |
| 04/13/2010 | CA2200868C Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 04/13/2010 | CA2189015C Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases |
| 04/13/2010 | CA2144056C Cd27 ligand |
| 04/13/2010 | CA2089229C Cd40cr receptor and ligands therefor |
| 04/13/2010 | CA2077154C Hcmv-specific peptides, agents therefor and the use thereof |
| 04/11/2010 | WO2010126137A1 Anti-cadherin antibody |
| 04/08/2010 | WO2010040105A2 Cd86 antagonist multi-target binding proteins |
| 04/08/2010 | WO2010040001A1 New hcv entry factor, occludin |
| 04/08/2010 | WO2010039900A2 Non-human mammals for the production of chimeric antibodies |
| 04/08/2010 | WO2010039873A2 Humanized endoglin antibodies |
| 04/08/2010 | WO2010039832A1 Anti-notch2 antibodies and methods of use |
| 04/08/2010 | WO2010039615A2 Papio cynocephalus toll-like receptor 3 |
| 04/08/2010 | WO2010039533A2 Methods for predicting production of activating signals by cross-linked binding proteins |
| 04/08/2010 | WO2010039154A1 Hepatitis c antibodies and uses thereof |
| 04/08/2010 | WO2010038974A2 Composition and kit for diagnosing immunoglobulin a nephropathy and tgbm nephropathy |
| 04/08/2010 | WO2010038831A1 Method, composition and kit for detecting diabetic complications accompanied by cell proliferation |
| 04/08/2010 | WO2010038830A1 Method, composition and kit for detecting tissue disorders induced by atrophy of collagen fibers |
| 04/08/2010 | WO2010038829A1 Method, composition and kit for detecting diabetic peripheral vascular disorder |
| 04/08/2010 | WO2010038789A1 Antibody capable of binding to envelope protein 2 of hepatitis c virus, and method for identifying genotype of hepatitis c virus using same |
| 04/08/2010 | WO2010038035A1 Carrier |
| 04/08/2010 | WO2010037856A2 DYNACTIN-1/p150glued AS A TARGET FOR TUMOR DIAGNOSIS AND THERAPY AND A METHOD FOR IDENTIFYING TARGETABLE DISEASE-RELATED PROTEINS |
| 04/08/2010 | WO2010037831A1 Anti cxcr4 antibodies and their use for the treatment of cancer |